News
IBIO
--
0.00%
--
Plant-based Biologics Market Increase In Transactional And Analytical Needs Across Several Industries 2027
Apr 10, 2021 (Market Insight Reports) -- Global Plant-based Biologics Market Rising demand for human biologics cannot be fulfilled by currently used...
Market Insight Reports · 3d ago
Human Papillomavirus Protein E7 Market: Global Industry Trends, Share, Size, Growth, Industry Statistics, Opportunity and Forecast 2021-2027
Apr 09, 2021 (Market Stats News via COMTEX) -- The latest report as Human Papillomavirus Protein E7 Market acknowledges Size, Application Segment, Type,...
Market Stats News · 4d ago
iBio Stock Shows Every Sign Of Being Significantly Overvalued
GuruFocus News · 4d ago
Coronavirus (COVID 19) Vaccine Pipeline Assessment Size, Share, Industry Report, Trends, Growth and Forecast 2020-2025
Japan, Japan, Fri, 09 Apr 2021 01:33:18 / Comserve Inc. / -- Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020" provides a comprehensive analysis of...
Comserve · 4d ago
Fauci says government won't mandate vaccine passports
"Anything is on the table. Anything is possible, of course," Dr. Anthony Fauci had said in January regarding a U.S. vaccine passport, though he dispelled the notion in a Politico
Seekingalpha · 04/06 08:58
iBio Inc. stock underperforms Monday when compared to competitors
marketwatch.com · 04/05 20:59
Yellow Fever Treatment Market Comprehensive Study By Key Players: Sanofi Pasteur SA, Bio-Manguinhos, Institut Pasteur de Dakar, FSUE Chumakov & so on…
Apr 01, 2021 (MARKITWIRED via COMTEX) -- Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and...
Markitwired · 04/01 10:33
Human Papillomavirus Protein E7 Market Analysis, Recent Trends, Development, Top Company Players and Forecast 2020-2027 by Ameco Research
pune, India, Tue, 30 Mar 2021 02:52:43 / Comserve Inc. / -- Ameco Research indicates that the Global Human Papillomavirus Protein E7 Market is expected to...
Comserve · 03/31 13:09
iBio Inc. stock falls Tuesday, underperforms market
Shares of iBio Inc. shed 3.85% to $1.50 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/30 21:00
iBio Inc. stock falls Monday, underperforms market
Shares of iBio Inc. slid 3.70% to $1.56 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial...
marketwatch.com · 03/29 21:00
Hereditary Angioedema Drug Market Insights, Global Size, Share, Industry Trend and Forecast 2020-2027 |Ameco Research
pune, India, Fri, 26 Mar 2021 01:35:27 / Comserve Inc. / -- Ameco Research adds " Hereditary Angioedema Drug Market 2020 Global Analysis, Growth, Trends and...
Comserve · 03/26 05:37
iBio Inc. stock outperforms market on strong trading day
Shares of iBio Inc. rallied 9.46% to $1.62 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/25 20:59
Hereditary Angioedema Drug Market 2021 By Top Manufacturers, Growth, Trends, Size, Share, Analysis and Forecast to 2027
Mar 25, 2021 (The Expresswire) -- The global “Hereditary Angioedema Drug Market” Report deliver comprehensive analysis of the market structure along with...
The Express Wire · 03/25 07:33
iBio Inc. stock underperforms Wednesday when compared to competitors
Shares of iBio Inc. shed 9.20% to $1.48 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/24 21:00
Alpha Galactosidase A Market Analytical Overview, Growth Factors, Demand, Trends and Forecast Report 2020-2027 by Ameco Research
pune, India, Wed, 24 Mar 2021 04:12:28 / Comserve Inc. / -- The "Alpha Galactosidase A Market - Market Analysis, Trends, and Forecasts" report has been added...
Comserve · 03/24 08:15
iBio Inc. stock underperforms Tuesday when compared to competitors
Shares of iBio Inc. slid 5.78% to $1.63 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/23 20:59
iBio Inc. stock rises Monday, still underperforms market
Shares of iBio Inc. inched 0.58% higher to $1.73 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...
marketwatch.com · 03/22 20:59
iBio Inc. stock underperforms Friday when compared to competitors despite daily gains
Shares of iBio Inc. advanced 1.18% to $1.72 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/19 20:59
iBio Inc. stock underperforms Thursday when compared to competitors
Shares of iBio Inc. slipped 2.30% to $1.70 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 03/18 20:59
Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020 Incredible Possibilities, Growth With Industry Study, Detailed Analysis and Forecast 2021-2025
AmericaNewsHour · 03/18 05:19
Webull provides a variety of real-time IBIO stock news. You can receive the latest news about IBIO through multiple platforms. This information may help you make smarter investment decisions.
About IBIO
iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.